dr. tyna moore glp-1 GLP-1s can change your life... BUT only if you use them correctly. ⠀ In this episode of Between Two Lips, @drtyna explains why many people stall out on GLP-1s SHE MD Podcast - The

Tirzepatide (Mounjaro for T2D, Zepbound for obesity) is a dual GIP and GLP-1 receptor agonist with a similar contraindication profile to semaglutide-based medications

The wrong technique can introduce shear stress, causing the fragile peptide bonds to fracture or the entire molecule to denature (unfold)

This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease, suggesting they have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like type 2 diabetes, overweight or obesity with cardiovascular disease, or CKD [chronic kidney disease], said lead author Sunil Badve, professorial fellow at The George Institute for Global Health and UNSW Sydney

Medications with narrow therapeutic windows (thyroid hormones, anticoagulants, certain antibiotics) may be absorbed differently when gastric emptying is slowed

Contact Us for Pudendal Neuralgia Treatment Now